These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15557613)

  • 1. The Leishmania major LACK antigen with an immunodominant epitope at amino acids 156 to 173 is not required for early Th2 development in BALB/c mice.
    Kelly BL; Locksley RM
    Infect Immun; 2004 Dec; 72(12):6924-31. PubMed ID: 15557613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional plasticity of the LACK-reactive Vbeta4-Valpha8 CD4(+) T cells normally producing the early IL-4 instructing Th2 cell development and susceptibility to Leishmania major in BALB / c mice.
    Maillard I; Launois P; Himmelrich H; Acha-Orbea H; Diggelmann H; Locksley RM; Louis JA
    Eur J Immunol; 2001 Apr; 31(4):1288-96. PubMed ID: 11298356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered ligands reveal limited plasticity in the T cell response to a pathogenic epitope.
    Pingel S; Launois P; Fowell DJ; Turck CW; Southwood S; Sette A; Glaichenhaus N; Louis JA; Locksley RM
    J Exp Med; 1999 Apr; 189(7):1111-20. PubMed ID: 10190902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered peptide ligands can modify the Th2 T cell response to the immunodominant 161-175 peptide of LACK (Leishmania homolog for the receptor of activated C kinase).
    Jensen KD; Sercarz EE; Gabaglia CR
    Mol Immunol; 2009 Jan; 46(3):366-74. PubMed ID: 19042022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell responses to immunodominant LACK antigen do not play a critical role in determining susceptibility of BALB/c mice to Leishmania mexicana.
    Torrentera FA; Glaichenhaus N; Laman JD; Carlier Y
    Infect Immun; 2001 Jan; 69(1):617-21. PubMed ID: 11119565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral immunization using live Lactococcus lactis co-expressing LACK and IL-12 protects BALB/c mice against Leishmania major infection.
    Hugentobler F; Di Roberto RB; Gillard J; Cousineau B
    Vaccine; 2012 Aug; 30(39):5726-32. PubMed ID: 22814408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leishmania major: targeting IL-4 in successful immunomodulation of murine infection.
    Wakil AE; Wang ZE; Locksley RM
    Exp Parasitol; 1996 Nov; 84(2):214-22. PubMed ID: 8932771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct immunological states in murine cutaneous leishmaniasis by immunising with different amounts of antigen: the generation of beneficial, potentially harmful, harmful and potentially extremely harmful states.
    Bretscher PA; Ogunremi O; Menon JN
    Behring Inst Mitt; 1997 Feb; (98):153-9. PubMed ID: 9382736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LACK-reactive CD4+ T cells require autocrine IL-2 to mediate susceptibility to Leishmania major.
    Gumy A; Aseffa A; Rachinel N; Breton M; Otten L; Tacchini-Cottier F; Röcken M; Doyen N; Acha-Orbea H; Locksley RM; MacDonald HR; Launois P; Louis J
    Eur J Immunol; 2006 Jun; 36(6):1465-73. PubMed ID: 16637008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The levels and patterns of cytokines produced by CD4 T lymphocytes of BALB/c mice infected with Leishmania major by inoculation into the ear dermis depend on the infectiousness and size of the inoculum.
    Lang T; Courret N; Colle JH; Milon G; Antoine JC
    Infect Immun; 2003 May; 71(5):2674-83. PubMed ID: 12704142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different epitopes of the LACK protein are recognized by V beta 4 V alpha 8 CD4+ T cells in H-2b and H-2d mice susceptible to Leishmania major.
    Launois P; Pingel S; Himmelrich H; Locksley R; Louis J
    Microbes Infect; 2007 Sep; 9(11):1260-6. PubMed ID: 17890126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cells that react to the immunodominant Leishmania major LACK antigen prevent early dissemination of the parasite in susceptible BALB/c mice.
    Schilling S; Glaichenhaus N
    Infect Immun; 2001 Feb; 69(2):1212-4. PubMed ID: 11160025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of the murine model of infection with Leishmania major to reveal the antagonistic effects that IL-4 can exert on T helper cell development and demonstrate that these opposite effects depend upon the nature of the cells targeted for IL-4 signaling.
    Louis JA; Gumy A; Voigt H; Launois P; Rocken M
    Pathol Biol (Paris); 2003 Mar; 51(2):71-3. PubMed ID: 12801805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In BALB/c mice, IL-4 production during the initial phase of infection with Leishmania major is necessary and sufficient to instruct Th2 cell development resulting in progressive disease.
    Himmelrich H; Launois P; Maillard I; Biedermann T; Tacchini-Cottier F; Locksley RM; Röcken M; Louis JA
    J Immunol; 2000 May; 164(9):4819-25. PubMed ID: 10779790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular cloning of a novel protein antigen of Leishmania major that elicits a potent immune response in experimental murine leishmaniasis.
    Webb JR; Kaufmann D; Campos-Neto A; Reed SG
    J Immunol; 1996 Dec; 157(11):5034-41. PubMed ID: 8943412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insight into the mechanisms underlying Th2 cell development and susceptibility to Leishmania major in BALB/c mice.
    Launois P; Himmelrich H; Tacchini-Cottier F; Milon G; Louis JA
    Microbes Infect; 1999 Jan; 1(1):59-64. PubMed ID: 10847767
    [No Abstract]   [Full Text] [Related]  

  • 17. Resistance to Leishmania major induced by tolerance to a single antigen.
    Julia V; Rassoulzadegan M; Glaichenhaus N
    Science; 1996 Oct; 274(5286):421-3. PubMed ID: 8832890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression cloning of a protective Leishmania antigen.
    Mougneau E; Altare F; Wakil AE; Zheng S; Coppola T; Wang ZE; Waldmann R; Locksley RM; Glaichenhaus N
    Science; 1995 Apr; 268(5210):563-6. PubMed ID: 7725103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-4 (IL-4) and IL-10 collude in vaccine failure for novel exacerbatory antigens in murine Leishmania major infection.
    Roberts MT; Stober CB; McKenzie AN; Blackwell JM
    Infect Immun; 2005 Nov; 73(11):7620-8. PubMed ID: 16239566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [LACK protein of Leishmania major: a pivotal antigen in the immune relation between host and parasite].
    Gangneux JP
    Sante; 1997; 7(6):425. PubMed ID: 9503502
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.